Venture • Life Science

General Atlantic Invests In Pharvaris

On November 18, 2020, growth capital firm General Atlantic invested in life science company Pharvaris

Investment Context
  • This is General Atlantic’s 11th transaction in the Life Science sector.
  • This is General Atlantic’s 4th transaction in the Netherlands.
Investment Fate
  • Pharvaris went public in 2021.

Explore All 557 Venture Life Science Deals - Search the Database Free


Investment Summary

Date November 18, 2020
Target Pharvaris
Sector Life Science
Investor(s) General Atlantic
Deal Type Venture

Target Company

Pharvaris

Leiden, Netherlands
Pharvaris is a clinical-stage company focused on the discovery and development of novel oral bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema (HAE), a rare and potentially life-threatening genetic condition. Pharvaris was founded in 2015 and is based in Leiden, Netherlands.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

General Atlantic

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1980
PE ASSETS 105.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

General Atlantic is a large private equity firm that invests globally in growth-oriented public and private companies. Broad areas of interest include financial services, media and consumer, healthcare, enterprise solutions, communications and electronics, and energy. General Atlantic looks to invest $40 to $400 million in transactions that support growth, expansions, buy-outs, consolidations and build-ups. General Atlantic seeks to make 8 to 12 investments per year with an investment horizon of five to ten years. The Firm's geographic coverage spans North America; Europe; Asia/Pacific; and India. General Atlantic was formed in 1980 and is based in New York, New York.


Deal Context for Investor #
Overall 260 of 365
Sector: Life Science 11 of 20
Type: Venture 59 of 98
Country: Netherlands 4 of 8
Year: 2020 25 of 29
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-11-06 Gen II Fund Services

New York, New York, United States

Gen II Fund Services is a fund administration provider focused entirely on serving the alternative asset management space, including private equity, real estate and credit funds. Gen II Fund Services was founded in 2009 and is based in New York, New York.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-04 Zimmermann

Rosebery, Australia

Zimmermann is a global luxury fashion brand that designs and sells iconic Ready-To-Wear and Swim & Resort collections through its online platform and own retail stores, as well as select department stores, boutiques, and online fashion retailers. Zimmermann was founded in 1991 and is based in Rosebery, Australia.

Sell -

Explore Related M&A Activity